Non-conformance monitoring and control techniques for an implantable medical device

• US 20060161376A1
• Filed: 02/21/2006
• Published: 07/20/2006
• Est. Priority Date: 12/29/2000
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Hartlaub, Jerome T.
• Granted Patent: US 7,505,869 B2
• Time in Patent Office: Days
• US Class Current: 702/138
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2205/3507 with implanted devices, e.g. external control
• CPC Class Codes: A61M 2205/3523 using telemetric means
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: G16H 20/17 delivered via infusion or injection

Abstract

Disclosed is a method and apparatus for determining whether an implantable drug delivery device is conforming to the performance requirements of the device or the needs of the patient. The system includes an implantable drug delivery device having stored therein at least one drug, a nonconformance monitor module monitoring pump parameters, an external programmer in telemetric communication with the implantable drug delivery device and having a nonconformance management module for determining whether the device is conforming to performance requirements, and to determine what action should be taken if non-conformance is determined. If the nonconformance management module identifies nonconformance, it determines what action should be taken for the particular non-conformance. The nonconformance management module will either invoke a pump programming change, or schedule and appointment or notify the patient that a non-programming change should be made.

Claims

1. A system for providing treatment therapy to a patient comprising in combination:

(a) an implantable drug delivery device comprising;

(i) a housing;

(ii) at least one drug reservoir within the housing and each configured to contain at least one drug;

(iii) a flow control module controlling the flow of drug from the drug reservoir through an infusion port;

(iv) electronics coupled to the flow control for adjusting the flow of drug by the flow control module;

(v) a telemetry module coupled to the electronics for providing bi-directional communication between the delivery device and an external programmer; and

(vi) a nonconformance monitor module coupled to the electronics, the drug monitor configured to monitor at least one pump performance parameter and generating pump performance data; and

(b) an external programmer comprising;

(i) memory having stored therein pump performance acquisition instructions;

(ii) a telemetry module providing bi-directional communication between the external programmer and the implantable drug delivery device and providing the pump performance acquisition instructions to the implantable drug delivery device and receiving pump performance data from the implantable drug delivery device, the pump performance data is selected from the group consisting of pump reservoir pressure, fluid outlet pressure, propellant pressure, fluid flow rate, battery current drain, motor current drain, motor drive current profile, battery voltage, and physiologic sensor output level; and

(iii) a nonconformance management module stored in the second memory for determining whether the pump is conforming to performance requirements, based upon the pump performance data from the drug monitor module, and determining what action should be taken if non-conformance is determined.

2. The system of claim 1, further comprising:

(c) at least one entity selected from the group consisting of an insurance provider, a pharmacy, a hospital, a caregiver, a physician, and a device manufacturer; and

(d) a computing network coupling the external programmer to the entity.

3. The system of claim 1, wherein the memory of the external programmer further includes patient performance requirements information.

4. The system of claim 1, wherein the memory of the external programmer further includes pump manufacturer requirements information.

5. The system of claim 1, wherein the memory of the external programmer further includes a scheduling module for scheduling an appointment to service the implantable drug delivery device.

6. The system of claim 5, wherein the scheduling module is capable of contacting at least one entity for the appointment, wherein the entity is selected from the group consisting of a pharmacy, a caregiver, a physician, a hospital, and the patient.

7. An implantable drug delivery device having performance data reporting capability comprising in combination:

(a) a housing;

(b) a drug reservoir carried in the housing configured to contain at least one drug;

(c) a flow control module coupled to the drug reservoir for controlling the flow of the drug from the drug reservoir through an infusion port;

(d) electronics coupled to the flow control and a power source;

(e) a telemetry module coupled to the electronics;

(f) a memory coupled to the electronics, the memory containing pump performance acquisition instructions;

(g) at least one monitoring module coupled to the memory and the electronics that monitors at least one pump operation variable according to the pump performance acquisition instructions to produce performance data;

(h) a non-conformance management module receiving the pump performance data, determining whether the pump is conforming to performance requirements, and determining what action should be taken if non-conformance is determined; and

(i) at least one reporting module coupled to the memory and the electronic, the reporting module configured to activate the telemetry module to report performance data.

8. The implantable drug delivery device of claim 7, wherein the non-conformance management module further determines whether the pump performance data is indicative of a non-programming change to the implantable drug delivery device.

9. The implantable drug delivery device of claim 8, wherein the non-conformance management module further performs the non-programming change to the implantable drug delivery device.

10. The implantable drug delivery device of claim 7, wherein the non-conformance management module further determines whether the pump performance data is indicative of a programming change to the implantable drug delivery device.

11. The implantable drug delivery device of claim 10, wherein the non-conformance management module further performs the programming change to the implantable drug delivery device.

12. The implantable drug delivery device of claim 7, wherein the pump performance data is selected from the group consisting of pump reservoir pressure, fluid outlet pressure, propellant pressure, fluid flow rate, battery current drain, motor current drain, motor drive current profile, battery voltage, and physiologic sensor output level.

13. The implantable drug delivery device of claim 7, wherein the non-conformance management module reports the pump performance data to an external device through the telemetry module.

14. A method for reporting implantable drug delivery device performance data, comprising:

(a) establishing pump performance acquisition instructions;

(b) operating the pump;

(c) monitoring pump variables according to the pump performance acquisition instructions;

(d) recording pump performance data; and

(e) reporting the pump performance data from the implantable drug delivery device to an external device via telemetry.

15. The method of claim 14, wherein the pump performance data is selected from the group consisting of pump reservoir pressure, fluid outlet pressure, propellant pressure, fluid flow rate, battery current drain, motor current drain, motor drive current profile, battery voltage, and physiologic sensor output level.

16. The method of claim 14, further comprising f) determining whether the pump is conforming to performance requirements.

17. A method for controlling an implantable drug delivery device to conform with performance requirements:

(a) receiving pump diagnostic data regarding the pump, the pump diagnostic data comprising pump performance data;

(b) comparing the data with at least one parameter selected from the group consisting of pump performance acquisition instructions, patient performance requirements, pump manufacturer requirements, and pump telemetry data;

(c) determining whether the pump is conforming with performance requirements provided by the parameter; and

(d) if the pump is not in conformance, determining whether to reprogram the pump or to require a non-programming change.

18. The method for controlling an implantable drug delivery device of claim 17, further comprising:

(e) if the pump is to be reprogrammed, altering at least one pump parameter.

19. The method of claim 17, wherein the pump performance data is selected from the group consisting of pump reservoir pressure, fluid outlet pressure, propellant pressure, fluid flow rate, battery current drain, motor current drain, motor drive current profile, battery voltage, and physiologic sensor output level.

20. The method of claim 17, further comprising:

(e) reporting the pump diagnostic data from the implantable drug delivery device to an external device via telemetry.